• linkedin
  • Increase Font
  • Sharebar

    Bill would lift Stark barriers to APMs

    Legislation would help with care coordination, supporters say


    House approves IPAB repeal

    Meanwhile, urology organizations experienced a significant victory in November when the House of Representatives approved legislation to eliminate the Independent Payment Advisory Board (IPAB) by a vote of 307-111.

    Authored by Reps. Phil Roe (R-TN) and Raul Ruiz (D-CA), the bill, if passed by the Senate and signed by President Trump, would repeal the provision of the ACA that created the IPAB as an effort to identifying Medicare savings. Physician organizations, such as those representing urology, argued that the IPAB would target Medicare reimbursement and that they would have little recourse to combat those cuts.

    Read: PCa active surveillance trends revealed in ‘real-world’ study

    Nearly 800 organizations representing patients, health care providers, seniors, veterans, and others—including the AUA, LUGPA, and the AACU—fought to convince Congress to repeal the IPAB.

    “Today, the House acted yet again to repeal this board and its unconstitutional relinquishment of Congressional authority,” said House Health Subcommittee Chairman Michael C. Burgess, MD (R-TX). “I urge the Senate to follow suit so we can return oversight of the future of the Medicare program where it belongs. We must prevent potential cuts from being implemented by this unelected board once and for all.”

    While the IPAB was created by the ACA, its members have never been appointed because the trigger for it to be implemented was never reached.

    More from Urology Times:

    LUGPA advocacy targets self-referral laws, USPSTF reform

    LUGPA puts resources behind key policy initiatives, future leaders

    Urology-specific APMs to encompass PCa, BPH, OAB

    Subscribe to Urology Times to get monthly news from the leading news source for urologists.

    Bob Gatty
    Bob Gatty, a former congressional aide, covers news from Washington for Urology Times.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available